Zobrazeno 1 - 9
of 9
pro vyhledávání: '"P. V. Koroy"'
Publikováno v:
Архивъ внутренней медицины, Vol 14, Iss 4, Pp 251-259 (2024)
In most cases, portal vein thrombosis progresses without treatment; spontaneous recanalization of portal vein develops in 42 % of patients with liver cirrhosis. Effective treatment strategies include administration of anticoagulants, interventional p
Externí odkaz:
https://doaj.org/article/954026aff9db4017b07879d9bf2f3f68
Publikováno v:
Архивъ внутренней медицины, Vol 14, Iss 3, Pp 165-172 (2024)
Portal vein thrombosis is the most common thrombotic complication in patients with liver cirrhosis, especially in cases of severe forms. The pathogenesis is multifactorial in nature, it determined by a change in the balance between the coagulation an
Externí odkaz:
https://doaj.org/article/e95527ffd80e44aa9b38d5e4f97019c8
Publikováno v:
Архивъ внутренней медицины, Vol 13, Iss 5, Pp 385-391 (2023)
The article presents an observation of a rare benign lymphoproliferative disease — Castleman’s disease, with pronounced systemic symptoms. The clinical case is of interest not only for the rarity of pathology, but also for the peculiarities of cl
Externí odkaz:
https://doaj.org/article/25efeb959f9f425fb3fe9d4692009b56
Autor:
M. V. Maevskaya, V. D. Lunkov, N. I. Geyvandova, L. K. Palgova, I. Yu. Pirogova, M. K. Prashnova, N. V. Marchenko, E. N. Zinovieva, T. A. Ilchishina, V. T. Ivashkin, P. V. Koroy
Publikováno v:
Медицинский совет, Vol 0, Iss 15, Pp 78-89 (2020)
Introduction. The increase in serum transaminases (ALT and AST) and the persistence of their high values is associated with morbidity and mortality from liver diseases. Bicyclol has anti-inflammatory and antioxidant effects, which formed the basis fo
Externí odkaz:
https://doaj.org/article/b81f10d8b7224f1fa30bd7ebc33da855
Autor:
V. T. Ivashkin, I. G. Bakulin, P. O. Bogomolov, M. V. Matsiyevich, N. I. Geyvandova, P. V. Koroy, S. V. Nedogoda, O. A. Sablin, L. G. Lenskaya, Ye. V. Beloborodova, A. A. Bagretsova, R. A. Abdulkhakov, M. F. Osipenko, I. V. Osipova, D. A. Pocheptsov, Ye. V. Chumachek, O. M. Khromtsova, Ye. V. Kuzmicheva
Publikováno v:
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, Vol 27, Iss 2, Pp 34-43 (2018)
Aim of investigation. To estimate efficacy and safety of two pharmacological forms of «Phosphogliv» (lyophilizate for intravenous administration and capsules) for the treatment of fatty liver degeneration of non-alcoholic etiology. Material and met
Externí odkaz:
https://doaj.org/article/4131ff0071c74aa1ac7482e20794c338
Publikováno v:
Медицинский совет, Vol 0, Iss 14, Pp 68-74 (2016)
Introduction in practice of therapeutic establishments in the RF of antiviral therapy of chronic viral hepatitis in the form of interferon-free schemes led to considerable increase of the frequency of the stable virologic response. Study objective: d
Externí odkaz:
https://doaj.org/article/5e835d095ebf4632b748aa9cc38f8b9d
Publikováno v:
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, Vol 24, Iss 5, Pp 22-28 (2014)
Aim of investigation. To establish interrelation of intercellular interaction mediators with histological changes at chronic viral liver disease.Material and methods. Blood contents of immunoglobulins superfamily and selectin molecules was investigat
Externí odkaz:
https://doaj.org/article/02002bca9482444e984b94c815fb2bc0
Publikováno v:
Experimental and Clinical Gastroenterology. :50-56
The aim of the work was to study the relationship of selectins with hepatic fi brosis in nonalcoholic fatty liver disease (NAFLD).Material and methods. In 40 patients with histologically confi rmed NAFLD (42.5% of women, 57.5% of men) aged 19 to 65
Autor:
P. V. Koroy, L K Palgova, Vladimir Ivashkin, M. K. Prashnova, M. V. Maevskaya, I. Yu. Pirogova, V. D. Lunkov, T. A. Ilchishina, N. I. Geyvandova, N. V. Marchenko, E. N. Zinovieva
Publikováno v:
Медицинский совет, Vol 0, Iss 15, Pp 78-89 (2020)
Introduction. The increase in serum transaminases (ALT and AST) and the persistence of their high values is associated with morbidity and mortality from liver diseases. Bicyclol has anti-inflammatory and antioxidant effects, which formed the basis fo